{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:16:53Z","timestamp":1792293413054,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.phrs.2022.106176","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:40:05Z","timestamp":1646912405000},"page":"106176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["8-Shogaol inhibits rheumatoid arthritis through targeting TAK1"],"prefix":"10.1016","volume":"178","author":[{"given":"Seongin","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha","family":"Samarpita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Su","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Eun","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungpyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ah","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Uk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahaboobkhan","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanguine","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.phrs.2022.106176_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2022.106176_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/BOR.0000000000000148","article-title":"The role of the synovial fibroblast in rheumatoid arthritis pathogenesis","volume":"27","author":"Turner","year":"2015","journal-title":"Curr. Opin. Rheuma"},{"issue":"5","key":"10.1016\/j.phrs.2022.106176_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheuma Int."},{"issue":"11","key":"10.1016\/j.phrs.2022.106176_bib4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the global burden of disease study 2017","volume":"78","author":"Safiri","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2022.106176_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","article-title":"Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis","volume":"19","author":"Bustamante","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106176_bib6","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.phrs.2022.106176_bib7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"issue":"23","key":"10.1016\/j.phrs.2022.106176_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239067","article-title":"Effects of biological therapies on molecular features of rheumatoid arthritis","volume":"21","author":"Lopez-Pedrera","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/art.27285","article-title":"Synovial fibroblasts self-direct multicellular lining architecture and synthetic function in three-dimensional organ culture","volume":"62","author":"Kiener","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2022.106176_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/art.10126","article-title":"Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis","volume":"46","author":"Marinova-Mutafchieva","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib11","first-page":"321","article-title":"Morphologic demonstration of two stages in the development of type II collagen-induced arthritis","volume":"46","author":"Caulfield","year":"1982","journal-title":"Lab Invest"},{"issue":"19","key":"10.1016\/j.phrs.2022.106176_bib12","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0024-3205(97)00480-3","article-title":"Collagen-induced arthritis, an animal model of autoimmunity","volume":"61","author":"Myers","year":"1997","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106176_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.berh.2008.01.004","article-title":"The role of resident synovial cells in destructive arthritis","volume":"22","author":"Ospelt","year":"2008","journal-title":"Best. Pr. Res. Clin. Rheuma"},{"issue":"1","key":"10.1016\/j.phrs.2022.106176_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41467-018-02935-4","article-title":"The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts","volume":"9","author":"Armaka","year":"2018","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.phrs.2022.106176_bib15","doi-asserted-by":"crossref","first-page":"eaba4353","DOI":"10.1126\/sciadv.aba4353","article-title":"Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal","volume":"6","author":"Svensson","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Disco"},{"issue":"39","key":"10.1016\/j.phrs.2022.106176_bib17","doi-asserted-by":"crossref","first-page":"23553","DOI":"10.1074\/jbc.M115.662445","article-title":"Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways","volume":"290","author":"Byun","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2022.106176_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s12094-007-0138-9","article-title":"Natural products as leads to anticancer drugs","volume":"9","author":"Gordaliza","year":"2007","journal-title":"Clin. Transl. Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106176_bib19","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.ejmech.2011.07.057","article-title":"Natural products: an evolving role in future drug discovery","volume":"46","author":"Mishra","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"31","key":"10.1016\/j.phrs.2022.106176_bib20","doi-asserted-by":"crossref","first-page":"eaay9131","DOI":"10.1126\/sciadv.aay9131","article-title":"Synthetic lethality by targeting the RUVBL1\/2-TTT complex in mTORC1-hyperactive cancer cells","volume":"6","author":"Shin","year":"2020","journal-title":"Sci. Adv."},{"issue":"D1","key":"10.1016\/j.phrs.2022.106176_bib21","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.phrs.2022.106176_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jmb.2005.09.098","article-title":"Structural basis for the interaction of TAK1 kinase with its activating protein TAB1","volume":"354","author":"Brown","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"16","key":"10.1016\/j.phrs.2022.106176_bib23","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2022.106176_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.phrs.2022.106176_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114917","article-title":"Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis","volume":"391","author":"Samarpita","year":"2020","journal-title":"Toxicol. Appl. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2022.106176_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8090342","article-title":"Anti-Inflammatory, anti-arthritic and anti-nociceptive activities of nigella sativa oil in a rat model of arthritis","volume":"8","author":"Nasuti","year":"2019","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.phrs.2022.106176_bib27","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1038\/s41598-019-44485-9","article-title":"Herbo-mineral formulation \u2018Ashwashila\u2019 attenuates rheumatoid arthritis symptoms in collagen-antibody-induced arthritis (CAIA) mice model","volume":"9","author":"Balkrishna","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2022.106176_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.20001","article-title":"Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion","volume":"50","author":"Lubberts","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106176_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3389\/fmed.2018.00364","article-title":"IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels","volume":"5","author":"Robert","year":"2018","journal-title":"Front Med."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192048","article-title":"Interleukin-17 in rheumatoid arthritis: trials and tribulations","volume":"217","author":"Taams","year":"2020","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106176_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/icb.2013.15","article-title":"Regulation of TNF-alpha with a focus on rheumatoid arthritis","volume":"91","author":"Moelants","year":"2013","journal-title":"Immunol. Cell Biol."},{"issue":"Suppl 3","key":"10.1016\/j.phrs.2022.106176_bib32","first-page":"iii2","article-title":"The role of interleukin-1 in the pathogenesis of rheumatoid arthritis","volume":"43","author":"Kay","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2022.106176_bib33","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3389\/fimmu.2019.01726","article-title":"Additive or synergistic interactions between IL-17A or IL-17F and TNF or IL-1beta depend on the cell type","volume":"10","author":"Noack","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106176_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119034","article-title":"Role of CCL2\/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches","volume":"269","author":"Moadab","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.phrs.2022.106176_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/ar2457","article-title":"The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis","volume":"10","author":"Brown","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106176_bib36","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000158","article-title":"The IKK complex, a central regulator of NF-kappaB activation","volume":"2","author":"Israel","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106176_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/ar1810","article-title":"MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?","volume":"7","author":"Meyer","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2022.106176_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1189\/jlb.68.6.909","article-title":"TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide","volume":"68","author":"Lee","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"5265","key":"10.1016\/j.phrs.2022.106176_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1126\/science.272.5265.1179","article-title":"TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction","volume":"272","author":"Shibuya","year":"1996","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.phrs.2022.106176_bib41","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1074\/jbc.M407537200","article-title":"Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-beta-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2","volume":"280","author":"Singhirunnusorn","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1721727X17727997","article-title":"Effects of Zingiber officinale extract on collagen-induced arthritis in mice and IL-1 beta-induced inflammation in human synovial fibroblasts","volume":"15","author":"Hwang","year":"2017","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.phrs.2022.106176_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2210-6-12","article-title":"6-Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freund\u2019s adjuvant","volume":"6","author":"Levy","year":"2006","journal-title":"BMC Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1021\/np8006183","article-title":"Comparative effects of two gingerol-containing Zingiber officinale extracts on experimental rheumatoid arthritis","volume":"72","author":"Funk","year":"2009","journal-title":"J. Nat. Prod."},{"issue":"12","key":"10.1016\/j.phrs.2022.106176_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145539","article-title":"Metabolomic elucidation of the effects of curcumin on fibroblast-like synoviocytes in rheumatoid arthritis","volume":"10","author":"Ahn","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.phrs.2022.106176_bib46","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/1529-0131(200111)44:11<2531::AID-ART433>3.0.CO;2-J","article-title":"Effects of a ginger extract on knee pain in patients with osteoarthritis","volume":"44","author":"Altman","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.phrs.2022.106176_bib47","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3906\/sag-2004-105","article-title":"Mango ginger (Curcuma amada) inhibits collagen-induced arthritis by modulating inflammatory cytokine levels in rats","volume":"50","author":"Karatas","year":"2020","journal-title":"Turk. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106176_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020466","article-title":"Comparison of inhibitory capacities of 6-, 8- and 10-gingerols\/shogaols on the canonical NLRP3 inflammasome-mediated IL-1beta secretion","volume":"23","author":"Ho","year":"2018","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.phrs.2022.106176_bib49","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1021\/jf904563c","article-title":"Induction of apoptosis by [8]-shogaol via reactive oxygen species generation, glutathione depletion, and caspase activation in human leukemia cells","volume":"58","author":"Shieh","year":"2010","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib50","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.117.243493","article-title":"Dual blockade of interleukin-1beta and interleukin-17A reduces murine arthritis pathogenesis but also leads to spontaneous skin infections in nonhuman primates","volume":"364","author":"Ruzek","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2022.106176_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.38896","article-title":"Combined inhibition of tumor necrosis factor alpha and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10456-021-09787-5","article-title":"TAK1 signaling is a potential therapeutic target for pathological angiogenesis","volume":"24","author":"Zhu","year":"2021","journal-title":"Angiogenesis"},{"issue":"9","key":"10.1016\/j.phrs.2022.106176_bib53","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200099","article-title":"TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases","volume":"10","author":"Totzke","year":"2020","journal-title":"Open Biol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10753-017-0534-4","article-title":"Adenovirus-mediated small interfering RNA targeting TAK1 ameliorates joint inflammation with collagen-induced arthritis in mice","volume":"40","author":"Luo","year":"2017","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib55","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.172.3.1612","article-title":"Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis","volume":"172","author":"Hammaker","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106176_bib56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13075-019-2073-x","article-title":"Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice","volume":"21","author":"Scarneo","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib57","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jcmgh.2021.04.016","article-title":"TAK1 is a novel target in hepatocellular carcinoma and contributes to sorafenib resistance","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.phrs.2022.106176_bib58","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood-2010-02-269605","article-title":"In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells","volume":"116","author":"Courties","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2022.106176_bib59","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar2215","article-title":"Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytes","volume":"9","author":"Hammaker","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2022.106176_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cels.2017.10.015","article-title":"Widespread rewiring of genetic networks upon cancer signaling pathway activation","volume":"6","author":"Billmann","year":"2018","journal-title":"Cell Syst."},{"issue":"11","key":"10.1016\/j.phrs.2022.106176_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010069","article-title":"Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts","volume":"17","author":"Corbet","year":"2021","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.phrs.2022.106176_bib62","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/sj.onc.1210255","article-title":"Oncogenic re-wiring of cellular signaling pathways","volume":"26","author":"Pawson","year":"2007","journal-title":"Oncogene"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:36:06Z","timestamp":1760913366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":62,"alternative-id":["S1043661822001219"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106176","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"8-Shogaol inhibits rheumatoid arthritis through targeting TAK1","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106176"}}